ERRFI1 and neoplasm: We focused on PTC, as the BRAF V600E mutation is a frequent genetic alteration in PTC, with frequencies of up to 73%, and as previous studies had indicated a potential tumor suppressor function of MIG-6 in this disease [17, 48, 49].